New Carotid Stent Systems Associated With Low Stroke Risk
With complication rates of 1% or less, Neuroguard and CGuard are renewing optimism about CAS, experts said at VIVA 2023.
Source: tctmd.com
Daniel Clair News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Daniel Clair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Daniel Clair Today - Breaking & Trending Today
PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI
Careful follow-up and good wound care are key to ensuring success in “no-option” patients, says Daniel Clair.
Source: tctmd.com
Vascular InterVentional Advances Conference, VIVA23, Clinical Trial Outcomes: PROMISE II (LimFlow) Trial for TADV, PRELUDE Study (LimbSonic) Therapeutic Ultrasound Presented
Results from five clinical trials were presented during the VIVA (Vascular InterVentional Advances) Conference, VIVA23, providing outcomes from studies on treatment for chronic limb-threatening ischemia (CLTI), use of drug-coated balloons, among other highly-anticipated late-breaking science findings.
Source: dicardiology.com
First Round of Late-Breaking Clinical Trial Results Announced at VIVA23
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
Source: prnewswire.com
FDA Approves LimFlow System in Patients with Chronic Limb-threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
New therapeutic option has potential to reduce rate of major limb amputation in US
Source: dicardiology.com